Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.

Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.

Item

http://www.wikidata.org/entity/Q36979305

Q36979305

about

Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.

Item

http://www.wikidata.org/entity/Q36979305

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Optimal Duration of Daily Anti ...... sing Restricted Cubic Splines.

@en

type

Item

label

Optimal Duration of Daily Anti ...... sing Restricted Cubic Splines.

@en

prefLabel

Optimal Duration of Daily Anti ...... sing Restricted Cubic Splines.

@en

P1476

Optimal Duration of Daily Anti ...... sing Restricted Cubic Splines.

@en

P2093

Manoranjan Midde

http://www.w3.org/2001/XMLSchema#string

Praveen Kumar Naik

http://www.w3.org/2001/XMLSchema#string

Raghavakalyan Pakam

http://www.w3.org/2001/XMLSchema#string

P2860

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis

The impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, India

HIV and Tuberculosis: a Deadly Human Syndemic

Initial Antituberculous Regimen with Better Drug Penetration into Cerebrospinal Fluid Reduces Mortality in HIV Infected Patients with Tuberculous Meningitis: Data from an HIV Observational Cohort Study.

Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patients

Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India

Evaluating the yield of medical tests.

Effect of Formula Feeding and Breastfeeding on Child Growth, Infant Mortality, and HIV Transmission in Children Born to HIV-Infected Pregnant Women Who Received Triple Antiretroviral Therapy in a Resource-Limited Setting: Data from an HIV Cohort Stu

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

P304

704980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/704980

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Gerardo Alvarez-Uria

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285397229

http://www.w3.org/2001/XMLSchema#string

P698

27433510

http://www.w3.org/2001/XMLSchema#string

P932

4897228

http://www.w3.org/2001/XMLSchema#string

Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.

about

Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932